Science Explorer Back to mapMap
Discussion
Researcher · Pearl River Community College · United States

Arie Zask

Arie Zask publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways and Protein Kinase Regulation and GTPase Signaling.

ORCID 0000-0002-1991-1328 OpenAlex
World rank
#1,021,864
of 7,710,434 ranked researchers
Rank in United States
#332,908
of 1,627,098
Works
131
Citations
4.5k
Citations per work
34.4
h-index
39
i10-index 78Top 7.8% in Molecular Biology
Arie Zask

What does Arie Zask research?

Arie Zask's work is mostly in Biochemistry, Genetics and Molecular Biology (40%), Chemistry (19%), Medicine (11%).

Life Sciences: 52 works · 39.5% of their workBiochemistry, Genetics and Molecular Biology: 52 works · 39.5% of their workMolecular Biology: 42 works · 32.1% of their workCancer Research: 6 works · 4.5% of their workCell Biology: 4 works · 2.9% of their workEverything else: 40 works · 30.4% of their workPhysical Sciences: 25 works · 19.2% of their workChemistry: 25 works · 19.2% of their workOrganic Chemistry: 25 works · 19.2% of their workHealth Sciences: 14 works · 10.9% of their workMedicine: 14 works · 10.9% of their workOncology: 8 works · 6.4% of their workPharmacology: 6 works · 4.5% of their workTHEIR WORKArie Zask131works
Life Sciences40%Physical Sciences19%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5239.5%
  2. Everything else4030.4%
    1. Chemistry2519.2%
    1. Medicine1410.9%
  1. 1Molecular Biology32% of their works
  2. 2Organic Chemistry19% of their works
  3. 3Oncology6% of their works
  4. 4Cancer Research4% of their works
  5. 5Pharmacology4% of their works
  6. 6Cell Biology3% of their works

Research topics

Which keywords describe Arie Zask's research?

The keywords of their largest research topics: Cancer Therapy, mTOR, Signaling, Angiogenesis, Cell Signaling, Proteasome, Ubiquitin and Protein Kinases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Therapy384 topics
  2. Signaling261 topic
  3. mTOR261 topic
  4. Angiogenesis182 topics
  5. Cell Signaling182 topics
  6. Proteasome121 topic
  7. Ubiquitin121 topic
  8. Protein Kinases111 topic
  9. Ras Signaling111 topic
  10. Drug Discovery101 topic
  11. Matrix Metalloproteinases101 topic
  12. Natural Products101 topic
  13. Tissue Inhibitors of Metalloproteinases101 topic
  14. Fibroblast Activation Protein81 topic
  15. Quinones81 topic
  16. Toxicology81 topic
  17. Tumor Microenvironment81 topic
  18. Cell Division71 topic
  19. Microtubules71 topic

Where does Arie Zask work?

Arie Zask's main affiliation in the publication record is Pearl River Community College, United States.

How many publications and citations does Arie Zask have?

OpenAlex counts 131 works and 4,501 citations for Arie Zask, an h-index of 39, ranking #1,021,864 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Arie Zask. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.